QA: Biohaven Pharmaceutical Holding Co Ltd in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001689813_2021_Biohaven_Pharmaceutical_Holding_Co_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001689813, Biohaven Pharmaceutical Holding Co Ltd

  xvar xval
0 AssetsCurrent 603,406,000
1 IntangibleAssetsNetIncludingGoodwill 39,087,000
2 PropertyPlantAndEquipmentNet 9,340,000
3 remainder_Assets 35,142,000
4 LiabilitiesCurrent 276,760,000
5 LiabilitiesNoncurrent 20,815,000
6 remainder_Liabilities 721,589,000
7 CostOfGoodsAndServicesSold 17,694,000
8 SellingGeneralAndAdministrativeExpense 462,323,000
9 ResearchAndDevelopmentExpense 228,998,000
10 remainder_Expenses 10,227,000
11 remainder_Revenues 63,627,000
12 remainder_NetIncome -113,000,000
13 remainder_ComprehensiveNetIncome 2,133,000
  yvar yval
0 Assets 686,975,000
1 Liabilities 1,019,164,000
2 Expenses 719,242,000
3 Revenues 63,627,000
4 StockholdersEquity -332,189,000
5 NetIncome -768,615,000
6 ComprehensiveNetIncome -767,548,500
7 BaseVar 1,302,070,500
8 EconomicCapitalRatiobeforeLimitedLiability -1.75
9 EconomicCapitalRatio 1.10

Edgar->Model Mapping

Feature Distribution

Change over Time